Stephen From

Stephen From serves as the Chief Executive Officer and Board Member of Vicarious Surgical Inc. since August 2025, focusing on strategic execution and value creation in surgical robotics. Previously, From held the position of Chief Executive Officer at Aruna Bio, Inc., where leadership resulted in FDA IND clearance for an innovative exosome-based therapy for CNS diseases. A notable transformation occurred at Eyegate Pharmaceuticals, Inc., under From's presidency, where the company evolved from a startup to a NASDAQ-listed entity, securing over $135 million in licensing agreements. Early career highlights include serving as CFO for Centelion (Sanofi-Aventis) and in investment banking roles specializing in life sciences for prominent firms. From holds a Chartered Accountant designation and degrees in General Science and Accounting from Western University and Wilfrid Laurier University.